A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J’xactly Study)
Yasuo Okumura(Noguchi Hospital), Makoto Mo(Yokohama Minami Kyosai Hospital), Mashio Nakamura, Takanori Ikeda(Toho University), Masatoshi Koga(National Cerebral and Cardiovascular Center), Tsutomu Yamazaki(University of Tokyo Hospital), Takao Kobayashi(Hokkaido University), Morimasa Takayama(Sakakibara Hospital), Takeshi Yamashita(Cardiovascular Institute Hospital), Hiroshi Matsuo(Frederick National Laboratory for Cancer Research), Ikuo Fukuda, Hiroyoshi Yokoi(Kurume University), Norikazu Yamada(Tohoku University), Akihiro Niwa(Hiratsuka Kyosai Hospital), Atsushi Hirayama(Nihon University), Hideaki Maeda(Nihon University)
Cited by 23
Related Papers
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
IL-33–Responsive Lineage−CD25+CD44hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs
|The Journal of Immunology|2011|552
Brachial-Ankle Pulse Wave Velocity and the Risk Prediction of Cardiovascular Disease
|Hypertension|2017|538
The Danger Signal, Extracellular ATP, Is a Sensor for an Airborne Allergen and Triggers IL-33 Release and Innate Th2-Type Responses
|The Journal of Immunology|2011|490